Tag Archives: Laboratory and Testing

MyBioSource Now Offers One of the Largest ELISA Kit Collections Available to Researchers Globally

Scientists worldwide can now order fresh, ready-to-use ELISA kits or request fully custom ones directly from MyBioSource, with global shipping and transparent pricing

SAN DIEGO, Calif., May 29, 2026 (SEND2PRESS NEWSWIRE) — Finding the right ELISA kit for a research project can take days, comparing suppliers, checking species compatibility, and waiting weeks for delivery. MyBioSource was founded to address these challenges. The San Diego-based company has put together a large, well-organized collection of ELISA kits that researchers can browse, compare, and order in one place. The company’s focus has always been simple: give scientists what they need, when they need it, without overcharging them.

Image caption: MyBioSource Now Offers One of the Largest ELISA Kit Collections Available to Researchers Globally.

KITS FOR ALMOST EVERY SPECIES AND SAMPLE TYPE

MyBioSource carries ELISA kits for a wide range of species, including human, mouse, rat, rabbit, bovine, canine, porcine, goat, sheep, monkey, chicken, guinea pig, and several others. This matters because not every lab works with the same organism, and having to switch suppliers for a different species wastes both time and money.

Their kits also work across different sample types, including serum, plasma, tissue homogenates, and cell culture supernatants. Researchers studying hormones, cytokines, growth factors, or infectious disease markers can find relevant kits listed with full technical datasheets, so there is no need to contact support to figure out basic specs before ordering.

FRESHLY PREPARED KITS AND CUSTOM ELISA SOLUTIONS

Most suppliers keep large batches of pre-assembled kits sitting in storage. MyBioSource does things differently — each kit is put together after the order comes in.

That means the product reaches a researcher’s lab fresh, with a longer shelf life, leading to more accurate and consistent results. For projects where no standard kit fits the bill, MyBioSource also builds custom ELISA Immunoassay Kits tailored to specific targets, species, or assay formats. Their custom kits are ready in two to three weeks and cost the same as a regular catalog order, which most suppliers do not offer.

A member of the MyBioSource team put it plainly: “We don’t want researchers wasting weeks trying to find something that works. If it’s not in the catalog, we’ll build it for you at no extra charge.”

STREAMLINED ORDERING AND GLOBAL AVAILABILITY

Researchers can always find up-to-date availability information in the MyBioSource catalog, which is updated daily. The company believes that cost shouldn’t be the reason a study is postponed, and that keeping prices competitive is essential.

Orders are accepted worldwide, and the site allows users to narrow their search by species, target, or sample type before purchasing. All product pages contain the information the researcher needs to make a sound decision, and there are no “back and forth” emails to go. If your lab encounters something in your experiments that is not listed in the catalog, the custom kit service is at your fingertips. MyBioSource makes it easy: spend less time shopping, more time in the lab.

“We built MyBioSource so that researchers don’t have to spend half their week just sourcing the right kit. Everything they need is already there — and if it’s not, we make it happen fast,” said a MyBioSource Spokesperson.

ABOUT MYBIOSOURCE

MyBioSource, Inc. began in 2006 when three scientists decided there had to be a better way to access high-quality lab reagents. Today, the company operates out of San Diego, California, and carries more than 2 million products — ELISA kits, antibodies, recombinant proteins, PCR kits, peptides, and more. Research teams at universities, biotech companies, and pharmaceutical firms around the world use MyBioSource because the products are reliable and the process is straightforward. Visit https://www.mybiosource.com/ to explore the full catalog.

CONTACT INFORMATION
Company Name: MyBioSource, Inc.
Email: sales@mybiosource.com
Website: https://www.mybiosource.com/
Address: San Diego, California, USA
Phone: +1 (855) 692 4676 (Toll-free within US & Canada)
+1 (858) 633 0165
Landline: +1 (858) 633 0166

Visit us on social media:

Facebook – https://www.facebook.com/mybiosourceinc

X – https://x.com/mybiosource

LinkedIn: https://www.linkedin.com/company/my-bio-source

MEDIA ONLY CONTACT:
Francesca Brown
+1(855)692 4676
francesca@mybiosource.com

MULTIMEDIA:
IMAGE link for media: https://www.Send2Press.com/300dpi/26-0529-s2p-MyBioSource-300dpi.webp

Image caption: MyBioSource Now Offers One of the Largest ELISA Kit Collections Available to Researchers Globally.

NEWS SOURCE: MyBioSource Inc.

This press release was issued on behalf of the news source (MyBioSource Inc.), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/mybiosource-now-offers-one-of-the-largest-elisa-kit-collections-available-to-researchers-globally/

Reintroducing a Proven Performer – the FENYX+ – Now with Greater Flow Rates and Dispense Volumes

SYOSSET, N.Y., Sept. 30, 2025 (SEND2PRESS NEWSWIRE) — Fluid Metering Inc. is proud to unveil the FENYX+, a next generation pump engineered to meet the growing demands of high-flow fluidic control. As the evolutionary successor to the original FENYX variable dispense pump, the FENYX+ delivers approximately 230% greater flow rates and dispense volumes, setting a new benchmark in chemical metering performance.

Image caption: Fluid Metering Inc. FENYX+.

The FENYX+ is designed for seamless integration and long-term reliability. Each pump is manufactured in accordance with stringent quality standards to ensure optimal performance from the outset. The pump assembly features precision engineered components to meet the most demanding operational standards.

Key Product Features:

CeramPump® valveless technology simplifies architecture by utilizing only one moving part in the fluid path.
Sapphire-hard ceramic internals provide exceptional durability and precision, ensuring non-contact dispensing for millions of cycles.
Self priming, dispensing and flushing functions- all with a single device.

“The FENYX+ represents the next chapter in our fluidic innovation story. Building on the proven success of our original FENYX, we’ve engineered a pump that doesn’t just meet today’s high-flow demands – it anticipates tomorrow’s challenges. With 230% greater flow rates and dispense volumes, the FENYX+ demonstrates our unwavering commitment to pushing the boundaries of what’s possible in precision fluid control. This isn’t just an upgrade; it’s our promise to continue leading the evolution of fluidic solutions in life sciences,” said Sean Madden, Vice President, Product & Marketing at Fluid Metering, Inc.

Learn more: https://www.fluidmetering.com/products/fenyx-plus

About Fluid Metering Inc.

Fluid Metering Inc. has been a leader in precision fluid control for over 65 years. Our commitment to innovation and quality continues with the launch of the FENYX+, setting a new benchmark for performance in the industry.

For more information, please contact us at pumps@fluidmetering.com.

IMAGE link for media: https://www.fluidmetering.com/hs-fs/hubfs/Images/Products/OEM/FENYX+%20-%20S_transparent.png?width=555&height=555&name=FENYX+%20-%20S_transparent.png

NEWS SOURCE: Fluid Metering Inc

This press release was issued on behalf of the news source (Fluid Metering Inc), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/reintroducing-a-proven-performer-the-fenyx-now-with-greater-flow-rates-and-dispense-volumes/

Fluid Metering, Inc. Unveils FENYX: A Revolutionary Leap in Fluidic Precision

SYOSSET, N.Y. /ScoopCloud/ -- Fluid Metering Inc., a leading manufacturer of fluid control solutions, proudly announces the debut of its groundbreaking variable dispense pump, FENYX (patent pending), heralding a new era of fluidic precision. Crafted to meet the evolving needs of the life sciences field, the FENYX integrates an advanced miniaturized fluidic system, enabling precise control of microliter volumes across a wide spectrum of applications.

Not only does the FENYX variable dispense pump streamline flushing, priming, and dispensing into a single, cohesive unit, it also offers unmatched flexibility, allowing dispensing over various surfaces or wells through non-contact dispensing without requiring physical intervention. Pioneering components, such as a calibratable flag, anti-backlash mechanism, and encoder, address the escalating demand for heightened throughput, single microliter dispense volumes, and minimized downtime.

Harnessing Fluid Metering's renowned CeramPump(R) technology, the FENYX boasts a sleek, low-profile design, delivering the industry's expected levels of precision and accuracy even while dispensing over air. This breakthrough innovation is poised to redefine fluidic solutions within the diagnostic, biotechnology & medical device space, playing a pivotal role in achieving impactful outcomes.

"The FENYX isn't just a pump; it's a symbol of Fluid Metering's commitment to innovation and our relentless pursuit of excellence in fluidic solutions. The FENYX marks our bold entry into the variable dispense pump market, expanding our capabilities beyond fixed dispense pumps. Join us as we embark on this exciting journey towards shaping the future of fluidic precision in life sciences," said Sean Madden, Vice President, Commercial and Product Development at Fluid Metering Inc.

Learn more: https://www.fluidmetering.com/fenyx

About Fluid Metering Inc.:

Fluid Metering Inc. stands at the forefront of fluid control innovation, having revolutionized the industry with our patented valve-less rotating and reciprocating piston metering pump concept, providing unmatched pumping excellence and precise fluid control across Diagnostics, Biotechnology, and Medical Device applications. With over 60 years of OEM design experience, our engineering team is dedicated to meeting customer and application requirements with unparalleled accuracy, precision, and reliability.

Learn more at: https://www.fluidmetering.com/

Fluid Metering Inc., a leading manufacturer of fluid control solutions, proudly announces the debut of its groundbreaking variable dispense pump, FENYX (patent pending), heralding a new era of fluidic precision. Crafted to meet the evolving needs of the life sciences field, the FENYX integrates an advanced miniaturized fluidic system, enabling precise control of microliter volumes across a wide spectrum of applications.

Related link: https://www.fluidmetering.com/

Fluid Metering Announces New Distribution Partnership with Girtec AG

SYOSSET, N.Y. /ScoopCloud/ -- Fluid Metering Inc. (FMI) is pleased to announce that Switzerland-based Girtec AG was recently appointed a strategic distributor to cover sales of our ultra-precise fluid control metering and dispensing products in Germany, Switzerland, Austria, and Liechtenstein.

Girtec AG, founded in 2012, provides its fluidic products and services in the fields of medical, laboratory and analytical technology instrumentation while developing innovative reliable solutions in close cooperation with its customers.

"This recent distribution partnership is more than just a collaboration - it is the beginning of a groundbreaking era for first-class products and innovation in our market. This partnership not only brings outstanding products into the hands of our customers, but also sets a new benchmark for quality, reliability, and technological excellence. We proudly combine first-class products with our local presence to offer our customers unique added value," as stated by Christoph Girsberger, CEO and Owner at Girtec AG.

"We are excited about this strategic alliance between both organizations to help meet the growing demand for ultra precise microfluidic pumps for medical and life sciences applications within the region," as stated by Sean Madden, Vice President of Commercial and Product Development at Fluid Metering.

About Fluid Metering Inc.:

Fluid Metering, Inc. pioneered the first patented valveless rotating and reciprocating piston metering pump concept delivering pumping excellence and precise fluid control for OEM, Medical and Life Science applications. Fluid Metering's engineering team incorporates over 60 years of OEM design experience to meet specific customer and application requirements with Accuracy, Precision & Reliability!

Fluid Metering Inc. was established in 1959 and is headquartered in Syosset, New York.

Website: https://www.fluidmetering.com/

Fluid Metering Inc. (FMI) is pleased to announce that Switzerland-based Girtec AG was recently appointed a strategic distributor to cover sales of our ultra-precise fluid control metering and dispensing products in Germany, Switzerland, Austria, and Liechtenstein.

Related link: https://www.fluidmetering.com/

Divergent CRO Announces Launch of New Contract Research Organization

ATLANTA, Ga. /ScoopCloud/ -- Divergent CRO, a leading provider of clinical services to biotech and device companies, is pleased to announce the official launch of its new Contract Research Organization (CRO). This new venture aims to revolutionize the research and development process by offering comprehensive and tailored clinical services to meet the unique needs of the biotech and device industries.

With an unwavering commitment to excellence, Divergent CRO provides a wide range of services, including clinical trial management, regulatory affairs, data management, biostatistics, and medical writing. By leveraging our extensive expertise, we are dedicated to helping our clients accelerate the development of innovative biopharmaceuticals and medical devices.

Our team of highly skilled professionals, including experienced clinical researchers, project managers, and regulatory specialists, is dedicated to delivering the highest standards of quality and efficiency throughout each stage of the clinical trial process. We understand the challenges faced by biotech and device companies and are committed to providing flexible and cost-effective solutions to meet their specific needs.

Divergent CRO is equipped with cutting-edge technology and infrastructure to ensure the smooth execution of clinical trials. Our advanced data management systems and secure facilities ensure the confidentiality and integrity of study data, while our robust quality assurance processes guarantee compliance with regulatory requirements.

"We are thrilled to launch our new Contract Research Organization and partner with biotech and device companies to advance the development of life-changing therapies," said Divergent CRO's Owner-Partners. "Our team is dedicated to delivering exceptional results and providing the highest level of service to our clients. With our expertise and commitment to excellence, we are confident that we can make a significant impact on the success of their clinical programs."

Divergent CRO is now accepting inquiries and is available to discuss collaboration opportunities with biotech and device companies seeking to enhance their clinical research capabilities.

For more information, please visit Divergentcro.com or contact our business development team at Customerservice@divergentcro.com or (888) 342-1447.

About Divergent CRO:

Divergent CRO is a leading provider of clinical services to biotech and device companies. With a focus on innovation and quality, we strive to accelerate the development of life-changing therapies through our comprehensive and tailored clinical services. We thrive on leaving our clients and patients satisfied by improving human health and wellness. Our team of experts is dedicated to delivering exceptional results and providing the highest level of service to our clients. At Divergent CRO, we don't just manage clinical trials; we craft personalized solutions, striving to be the difference by transforming challenges into triumphs in the pursuit of groundbreaking healthcare innovation.

Learn more at: https://divergentcro.com/

Social Links:

LinkedIn Page: https://www.linkedin.com/company/divergentcro/

Instagram: https://www.instagram.com/divergent.cro/

TikTok: https://www.tiktok.com/@divergentcro1

YouTube: https://www.youtube.com/@DivergentCRO

Featured Podcasts:

The Jali Podcast - Melyssa Barrett/DivergentCRO - https://melyssabarrett.com/the-jali-podcast/

Episode Thirty-one - AMY HUTTO, PRODUCTIVITY COACH - https://amyhutto.com/podcast/s1ep30

Divergent CRO, a leading provider of clinical services to biotech and device companies, is pleased to announce the official launch of its new Contract Research Organization (CRO). This new venture aims to revolutionize the research and development process by offering comprehensive and tailored clinical services to meet the unique needs of the biotech and device industries.

Related link: https://divergentcro.com/

US Kidney Research Corp Unveils Breakthrough Ultrafilter Membrane for Dialysis

ROSEVILLE, Calif. /ScoopCloud/ -- US Kidney Research Corporation (USKRC) is delighted to announce new groundbreaking research as part of a contract with the University of Arkansas (U of A) resulting in the development of an ultrafiltration membrane with diverse filtering applications for medical and non-medical devices. This remarkable membrane represents a significant advancement, particularly in the field of dialyzers, the filtration device used in hemodialysis machines to remove toxins, promising improved dialysis performance and enhanced ultrafiltration flux.

The recently published research in Scientific Reports (https://www.nature.com/articles/s41598-023-37765-y) unveils a novel membrane created through a tempo cellulosic oxidation process and cast using ionic liquids. Notably, the membrane showcases exceptional biocompatibility, the ability to clear potential uremic toxins, and excellent stability. Its unique structure, characterized by the alignment of fibers after casting, leads to an extraordinarily high flux and substantial BSA rejection in ultrafiltration mode, surpassing the performance of traditional dialysis membranes.

"We were highly impressed by the membrane's behavior and performance; the fiber alignment in the final structure allows for superior functionality compared to conventional dialysis membranes," expressed Jamie Hestekin, one of the lead researchers at U of A.

As part of this concerted effort, USKRC has secured worldwide rights for the patented U of A membrane in all biomedical applications. USKRC's founder and CEO Roland Ludlow, revealed that the corporation intends to explore sublicensing partnerships both domestically and internationally, with the aim of expediting the introduction of this cutting-edge membrane technology to the market, enabling its use in dialysis and other relevant applications.

Dr. Ira Kurtz, Chief of Nephrology at UCLA, who is an author on the Scientific Reports paper and serves as the lead medical/scientific advisor to USKRC commented, "This new membrane chemistry could be a game changer in the care of renal patients."

USKRC is actively engaged in several other research projects, including the development of a waterless portable blood purifying device that could potentially replace current dialysis machines, an implantable artificial kidney, and a coating to prevent blood coagulation within medical device tubing and catheters. The company has solidified its position as a leader in renal therapy research, earning prestigious recognition as a two-time winner of the KidneyX contest, sponsored by the American Society of Nephrology and the US Department of Health and Human Services. Monetary awards for KidneyX were generously provided by the US Congress and the American Society of Nephrology.

About US Kidney Research Corporation:

US Kidney Research Corporation (formerly Curion Research Corporation), is an award-winning company incorporated in Delaware (C-Corp), founded in June, 2015. The company is creating the world's first waterless blood purification technology for use in a portable device and ultimately an implantable artificial kidney, as well as other novel technologies to improve the lives of patients with end stage renal disease (ESRD) or acute kidney injury (AKI). US Kidney Research Corporation has patents for its waterless blood purifying technology in USA, Japan, India, S. Korea, China, along with 17 European Unitary patent member countries.

More information: https://www.uskidneyresearchcorp.com/

US Kidney Research Corporation (USKRC) is delighted to announce new groundbreaking research as part of a contract with the University of Arkansas (U of A) resulting in the development of an ultrafiltration membrane with diverse filtering applications for medical and non-medical devices.

Related link: https://www.uskidneyresearchcorp.com/

Fluid Metering Announces New Distributor in UK and Ireland

SYOSSET, N.Y. /ScoopCloud/ -- Fluid Metering Inc., a pioneer in design and manufacturing of high-performance fluid handling solutions, is pleased to announce a new distribution agreement with Premier Control Technologies Limited (PCT) as the new distributor of precision fluid control solutions throughout the United Kingdom and Ireland.

Fluid Metering Inc, and PCT are well aligned with their company ethos, at the forefront is collaboration with both its suppliers and customers to ensure all expectations are met working within the science and laboratory segments, as well as the broader life sciences sector. Foremost, this alliance allows us to be well placed to be your partner of choice for your next project or OEM requirement.

"PCT are proud to be the partner of choice for Fluid Metering Inc, the technical and commercial needs of UK and Irish customers can now be met with local service and support," says James Kybird, Managing Director at Premier Control Technologies Limited. "Based in Hethel, Norfolk, our sales office remains the first point of contact with business development managers placed throughout the UK offering market and product expertise for customer applications requiring engineering support."

"Fluid Metering, Inc. is excited to have found a partner within the UK and Ireland that shares FMI's commitment to customer service and will be able to further our customer's success in those markets with local support," says Sean Madden, Vice President of Commercial & Product Development at Fluid Metering, Inc.

About Fluid Metering Inc.:

Fluid Metering continues to be a leader in the manufacturing of valve-less ceramic dispensers and metering pumps with strategic focus in the life science market space. Proudly, incorporating over 64 years of OEM design and experience to meet customer specific application requirements with Accuracy, Precision & Reliability!

Learn more at: https://www.fluidmetering.com/

Fluid Metering, Inc., a pioneer in design and manufacturing of high-performance fluid handling solutions, is pleased to announce a new distribution agreement with Premier Control Technologies Limited (PCT) as the new distributor of precision fluid control solutions throughout the United Kingdom and Ireland.

Related link: https://www.fluidmetering.com/

Laboratory Supply Distributors Corp. Launches New Chromatography Consumables Website and Brand

VINELAND, N.J. /ScoopCloud/ -- Laboratory Supply Distributors Corp. is excited to announce that it's launched a new brand - ChromOne. This new brand has an expanded chromatography consumable products line, website and logo too.

The new ChromOne website is user-friendly and offers the ultimate customer experience with improved navigation and functionality. The full product line is easy to access and well-organized.

"Our products deliver reliable performance while expediting and simplifying the analysis process," Clifton Hitchner, vice president, Laboratory Supply Distributors Corp., says. "We hope this new brand will provide customers with even greater access to the chromatography consumable products they need."

Some of its quality products include: chromatography vials, closures, septa, and inserts, HPLC and GC autosampler vials, HPLC and GC vials, caps and high-performance liquid chromatography products.

And as part of Laboratory Supply Distributor Corp.'s commitment to creating a positive customer experience, ChromOne has a ChromOne Rewards Program where customers receive volume discounts ranging from five to 15 percent.

About Laboratory Supply Distributors Corp.:

For more than 20 years Laboratory Supply Distributors Corp. has supplied chromatography and analytical products and instruments to the analytical, pharmaceutical, research and academic communities. Its product offerings include: glass and plastic vials, closures, and septa, laboratory filtration products, microplates and reservoirs, sample preparation products, environmental sample containers, nitrogen blowdown evaporators, laboratory instruments and more.

View the new ChromOne(R) website: https://chromone.com/.

Laboratory Supply Distributors Corp. is excited to announce that it's launched a new brand - ChromOne. This new brand has an expanded chromatography consumable products line, website and logo too.

Related link: https://lsdc.com/

Mopec Announces Distribution Partnership with StatLab to Bring You the Best Cassette Printer in North America

MADISON HEIGHTS, Mich. /ScoopCloud/ -- Mopec, a leading manufacturer of anatomic pathology grossing stations, announced their new distributor partnership with StatLab to allow their customers the opportunity to purchase StatLab PiSmart Cassette Printers directly from Mopec.

Widely reviewed as the best cassette printer on the market, the StatLab PiSmart Cassette Printer is designed to improve accuracy, efficiency, and automation in your lab. This new partnership will simplify the process for customers looking to upgrade their grossing station expenditures with additional equipment and accessories.

"Mopec prides itself on building the safest and most advanced grossing stations and pathology equipment in the market," said Carmen Evola, CEO of Mopec. "If there's something we can't build, we're going to partner with someone who can. Mopec is thrilled to work with StatLab to help us provide our customers with a product we trust from a company we can rely on."

The PiSmart Cassette Printer is available in two models, the PiSmart Single Plus and the PiSmart Six. The PiSmart Single Plus is suitable for on-demand printing and can deliver the first printed cassette in under three seconds. The PiSmart Six offers more functionality with 6 cassette hoppers and can be used for on-demand or batch printing.

Both models feature a built-in scanner as well as an internal label design software allowing the printer to be used efficiently without the use of a PC. The true on-demand printing and small footprint makes the PiSmart Cassette Printer ideal for integrating seamlessly with the Mopec Maestro Grossing Station, giving customers unparalleled convenience and workflow optimization in their lab.

"Mopec was in search of a cassette printer that met the same quality and convenience our customers have grown accustomed to when ordering from Mopec," said Jeff Pemberton, Vice President of Marketing & Consumables. "We wanted to provide an option that would integrate well with our Maestro grossing stations and that we felt comfortable putting our reputation behind. StatLab's PiSmart was the obvious choice."

Along with the PiSmart Cassette Printers, Mopec is also adding Pi Cassettes to their Consumables lineup. Pi Cassettes are designed specifically for use on the PiSmart printer. They utilize a patented feature that both protects the printed surface during dewaxing, while still enabling the surface to be cleared of wax.

For more information or to obtain a quotation, please visit https://www.mopec.com/, or call (800) 362-8491.

About Mopec:

Mopec, based in Madison Heights, Michigan, is a manufacturer and distributor of high-quality pathology, anatomy, mortuary, and necropsy equipment and products. Founded in 1992, Mopec differentiates itself through its extensive engineering process, superior design, and market-leading quality. Mopec is Elevating Pathology and specializes in solutions for forensic and anatomic pathology labs in hospitals, universities, morgues, and a variety of other markets. Mopec is committed to the production innovative products and providing high quality customer service. For more information, visit https://www.mopec.com/.

Mopec, a leading manufacturer of anatomic pathology grossing stations, announced their new distributor partnership with StatLab to allow their customers the opportunity to purchase StatLab PiSmart Cassette Printers directly from Mopec.

Related link: https://www.mopec.com/

SV Diagnostic Labs Launching Test Sites in Ohio and Kentucky to Access Safer COVID-19 Testing, Quicker Results

COLUMBUS, Ohio /ScoopCloud/ -- WHAT: Long lines are being reported in some cities around the country for those trying to access a COVID-19 PCR test - considered the most accurate COVID-19 test available. However, Ohio's privately owned SV Diagnostic Labs is ready and able to meet the demand in multiple states. SV Diagnostic Labs provides COVID-19 testing at various locations in Ohio, Kentucky and New Jersey with results usually provided within 24 hours.

SV Diagnostic Labs is also the only laboratory in Ohio offering access to the QuikSal™ oral rinse collection device. Developed and manufactured in the United States, QuikSal eliminates the need for an anxiety-inducing nasal swab. Each QuikSal collection device contains 2 ml of liquid which is swished in the mouth for one minute and then returned to the container. Test material is then processed at SV Diagnostic Labs in Dayton and test results emailed to the client.

WHERE: SV Diagnostic Labs operates main sites and now opening new satellite locations all across Central Ohio and Kentucky - drive-up testing locations allowing an individual to remain in their car. The most efficient way to receive a test is to register online https://www.svdiagnosticlab.com the site will geo cache your location and send you to the site closest to your location.

Prior to arriving at the test location. Those who do not register ahead of time will need to access a site specific QR code at each location before receiving the test.

* Columbus - 6400 East Broad Street, Columbus, Ohio

-- Hours: Monday through Friday, 9:00 a.m. - 5 p.m.

* Toledo - 5457 Secor Rd, Toledo, Ohio 43623

-- Hours: Monday through Friday, 9 a.m. - 5 p.m., Sunday 10 a.m. to 2 p.m.

* Louisville - 12450 Lagrange Rd, 46254 (parking lot of Kroger)

-- Hours: Monday through Friday, 9 a.m. - 5 p.m., Sunday 10 a.m. to 2 p.m.

* Lexington - 635 New Circle Rd, Lexington, KY, 40505

-- Hours: Monday through Friday, 9 a.m. - 5 p.m., Sunday 10 a.m. to 2 p.m.

The QuikSal™ oral rinse collection device is covered by private insurance, Medicare and Medicaid. Testing for those without insurance is covered through The Cares Act.

WHY: SV Diagnostic Labs is Ohio's premier privately owned, CLIA certified laboratory capable of a wide range of molecular diagnostic and Toxicology testing.

Learn more: https://www.svdiagnosticlab.com/

For More information contact:
SV Diagnostic Labs
614-254-6031

Long lines are being reported in some cities around the country for those trying to access a COVID-19 PCR test - considered the most accurate COVID-19 test available. However, Ohio's privately owned SV Diagnostic Labs is ready and able to meet the demand in multiple states. SV Diagnostic Labs provides COVID-19 testing at various locations in Ohio, Kentucky and New Jersey with results usually provided within 24 hours.

Related link: https://www.svdiagnosticlab.com/

New Frontier adds Women’s Health Services

KANSAS CITY, Mo. /ScoopCloud/ -- New Frontier Mobile Diagnostics now offers diagnostic ultrasounds for Women's Health (OB/GYN), adding to the scope of on-site imaging capabilities available to patients. Access to Women's Health services is a critical factor in the health of women, regardless of child-bearing status.

According to a 2019 study by the Kaiser Family Foundation, women seeking basic gynecological care incur significantly greater health care costs (84% higher for ages 18-44, 21% higher for 45 and older) and are more likely to go without care because of cost.

During pregnancies, studies have shown that limited access to care can result in negative outcomes including premature birth, low birth weight, maternal mortality, severe maternal morbidity, and an increased risk of postpartum depression.

"By bringing affordable, quality care on-site, New Frontier hopes to eliminate some of the challenges that women face when seeking healthcare," said Jeff Blackwood, Founder of New Frontier. "Your zip code, race, and income shouldn't be the primary factors determining the quality of care you receive. We want to make these services available to women where they need it, when they need it."

In addition to Women's Health services, New Frontier continues to serve doctor's offices, clinics, and facilities with on-site diagnostic imaging for cardiac, vascular, and general ultrasound services.

For more information on New Frontier Mobile Diagnostics and its services, please contact Jeff Blackwood at info@newfrontiermd.com.

About New Frontier Mobile Diagnostics

New Frontier, based in Kansas City, MO, brings quality, affordable care to patients in doctors' offices, clinics, and care facilities. It provides in-room diagnostic imaging services for heart, vascular, women's health and general imaging procedures. Its partnership with Healient Physician Group ensures informed, professional analysis, bringing patients access to quality diagnostic care, when they need it, where they need it.

For more information, go to https://newfrontiermd.com/.

New Frontier Mobile Diagnostics now offers diagnostic ultrasounds for Women's Health (OB/GYN), adding to the scope of on-site imaging capabilities available to patients. Access to Women's Health services is a critical factor in the health of women, regardless of child-bearing status.

Related link: https://newfrontiermd.com/

Solaris Diagnostics, A Kentucky-based Testing Laboratory, Donates 1,000 Oxygen Concentrators to India

NICHOLASVILLE, Ky. /ScoopCloud/ -- Solaris Diagnostics, a CLIA certified clinical laboratory in Nicholasville Kentucky, has shipped 1,000 donated oxygen concentrators, worth more than $700 thousand dollars, to India.

These oxygen concentrators are now providing life-saving relief to the millions of patients suffering from the devastating second wave of COVID-19 cases in India. The donated supplies began arriving this week and currently aid three Indian organizations: Office of District Collector and Magistrate, Hanumangarh, Rajasthan KhalsaAid India and Sewa International.

With more than 348,000 new cases reported and death numbers exceeding 4,200 daily, the country is experiencing a shortage in beds and oxygen supplies, resulting in dying patients being denied access into the hospitals.

"We heard that as our oxygenators were being dispersed to CMC hospitals in District of Hanumangarh, hospitals ran out of oxygen supply and were turning patients away. The shipment of oxygen concentrators provided relief to hundreds of patients waiting outside the hospital, saving lives," said Dr. Preetpal S. Sidhu, PhD, NRCC, CEO at Solaris Diagnostics.

"I heard directly from the family member whose elderly mother was discharged from hospital with 70% oxygen level and no chance of survival. She ultimately fought back with the help of one of the donated oxygen concentrators. I am overwhelmed with the positive stories pouring through my social media accounts. This is why we're doing this."

Solaris Diagnostics was one of the first testing sites in Kentucky, beginning testing in early March 2020. To date, the lab has performed more than 3.5 million COVID-19 tests, administering 40% of all COVID testing for the state of Kentucky. At the peak of COVID-19 testing, Solaris Diagnostics performed 44,000 COVID-19 samples in one day and averaged 30,000 daily tests. Solaris Diagnostics also served thousands of long-term health care centers, hospitals, and medical facilities across the nation.

"Our laboratory has continued to evolve during this pandemic to ensure the speed and continued operability of our COVID-19 operations in the foreseeable future," said John Drury, Chief Operating Officer at Solaris Diagnostics.

"We're prepared to serve our global citizens in the face of any pandemic or medical crisis," said Cole Aebersold, Chief Marketing Officer at Solaris Diagnostics. "Solaris will continue to be a testing resource for patients and health care providers locally and nationally."

Link to images of Solaris Diagnostic shipments being received in India: https://drive.google.com/drive/folders/1QYaogEcouX-KFr67rad3nBT7TOq-7RvA?usp=sharing

Solaris Diagnostics is a medical laboratory testing facility accredited under the Clinical Laboratory Improvement Amendments (CLIA) in Nicholasville, Kentucky. Solaris Diagnostics provides advanced diagnostic testing for physicians, clinicians, and medical facilities, offering both contemporary testing and cutting-edge molecular diagnostics. To learn more about Solaris, visit https://solarisdx.com/

MEDIA NOTICE: Media outlets are to correspond with the media contact to coordinate and schedule interviews.

Media Contact: Kirk Hilbrecht | Boxcar PR | kirk@boxcarpr.com | (502) 501-3591

PHOTO link for media: https://www.Send2Press.com/300dpi/21-0513s2p-Solaris-shipment-300dpi.jpg

Solaris Diagnostics, a CLIA certified clinical laboratory in Nicholasville Kentucky, has shipped 1,000 donated oxygen concentrators, worth more than $700 thousand dollars, to India.

Related link: https://solarisdx.com/